SCOPOLAMINE TRANSDERMAL SYSTEM

SCOPOLAMINE TRANSDERMAL SYSTEM was reported 267 times

These side effects are most commonly reported by patients taking SCOPOLAMINE TRANSDERMAL SYSTEM:

# Side effect Count
0 PRODUCT ADHESION ISSUE 163
1 OFF LABEL USE 81
2 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 51
3 DIZZINESS 37
4 DRUG INEFFECTIVE 28
5 NAUSEA 28
6 PRODUCT QUALITY ISSUE 20
7 PRODUCT USE IN UNAPPROVED INDICATION 14
8 VISION BLURRED 14
9 DRY MOUTH 13
10 FEELING ABNORMAL 12
11 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 11
12 VOMITING 11
13 MALAISE 9
14 VERTIGO 9
15 HALLUCINATION 8
16 MYDRIASIS 8
17 PRODUCT PRESCRIBING ISSUE 8
18 PRODUCT USE ISSUE 8
19 BALANCE DISORDER 6
20 CONFUSIONAL STATE 6
21 FATIGUE 6
22 ILLNESS 6
23 MATERNAL EXPOSURE DURING PREGNANCY 6
24 APPLICATION SITE ERYTHEMA 5
25 APPLICATION SITE RASH 5
26 DEATH 5
27 HEADACHE 5
28 NO ADVERSE EVENT 5
29 TREMOR 5
30 WEIGHT DECREASED 5
31 AGITATION 4
32 APPLICATION SITE IRRITATION 4
33 APPLICATION SITE PAIN 4
34 APPLICATION SITE PRURITUS 4
35 DIARRHOEA 4
36 DISORIENTATION 4
37 FALL 4
38 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4
39 PRURITUS 4
40 THERAPEUTIC PRODUCT EFFECT INCREASED 4
41 ABDOMINAL DISCOMFORT 3
42 AMNESIA 3
43 ANXIETY 3
44 APPLICATION SITE EROSION 3
45 APPLICATION SITE REACTION 3
46 DECREASED APPETITE 3
47 DYSPEPSIA 3
48 GAIT DISTURBANCE 3
49 RASH 3
50 THERAPEUTIC RESPONSE UNEXPECTED 3
51 WITHDRAWAL SYNDROME 3
52 ABNORMAL BEHAVIOUR 2
53 ADVERSE DRUG REACTION 2
54 APPLICATION SITE HAEMORRHAGE 2
55 APPLICATION SITE SCAB 2
56 APPLICATION SITE VESICLES 2
57 BRONCHIAL SECRETION RETENTION 2
58 CONDITION AGGRAVATED 2
59 DEHYDRATION 2
60 DRY THROAT 2
61 EMOTIONAL DISORDER 2
62 EXPIRED PRODUCT ADMINISTERED 2
63 EYE PAIN 2
64 FEELING DRUNK 2
65 FEELING JITTERY 2
66 GAIT INABILITY 2
67 HALLUCINATION, VISUAL 2
68 HYPERHIDROSIS 2
69 ILEUS 2
70 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2
71 MEMORY IMPAIRMENT 2
72 MOTION SICKNESS 2
73 OROPHARYNGEAL PAIN 2
74 PALPITATIONS 2
75 PARANOIA 2
76 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 2
77 PRODUCT COMMUNICATION ISSUE 2
78 PRODUCT DOSE OMISSION ISSUE 2
79 RESPIRATORY FAILURE 2
80 SLEEP DISORDER 2
81 SOMNOLENCE 2
82 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2
83 TOXICITY TO VARIOUS AGENTS 2
84 VISUAL IMPAIRMENT 2
85 ABDOMINAL PAIN UPPER 1
86 ACCIDENTAL OVERDOSE 1
87 ADENOCARCINOMA 1
88 ADVERSE EVENT 1
89 AFFECT LABILITY 1
90 AFFECTIVE DISORDER 1
91 ALOPECIA 1
92 ANAEMIA 1
93 APHASIA 1
94 APPLICATION SITE BURN 1
95 APPLICATION SITE MASS 1
96 APPLICATION SITE SCAR 1
97 APPLICATION SITE SWELLING 1
98 APPLICATION SITE URTICARIA 1
99 APTYALISM 1
100 ASTHENIA 1
101 BLISTER 1
102 BLOOD CHOLESTEROL INCREASED 1
103 BLOOD GLUCOSE INCREASED 1
104 BLOOD PRESSURE INCREASED 1
105 BLOOD SODIUM DECREASED 1
106 BONE PAIN 1
107 BRADYCARDIA 1
108 BRAIN FOG 1
109 CARDIAC ARREST 1
110 CHEST PAIN 1
111 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1
112 CLONIC CONVULSION 1
113 COGNITIVE DISORDER 1
114 COUGH 1
115 DELIRIUM 1
116 DEPRESSION 1
117 DERMATITIS 1
118 DIPLOPIA 1
119 DISEASE RECURRENCE 1
120 DISTURBANCE IN ATTENTION 1
121 DROOLING 1
122 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1
123 DYSPHAGIA 1
124 ERYTHEMA 1
125 EUPHORIC MOOD 1
126 EXTRA DOSE ADMINISTERED 1
127 FEEDING DISORDER 1
128 FEELING HOT 1
129 FINE MOTOR SKILL DYSFUNCTION 1
130 GENERAL PHYSICAL HEALTH DETERIORATION 1
131 GINGIVAL HYPERTROPHY 1
132 HEAD DISCOMFORT 1
133 HEART RATE INCREASED 1
134 HOSPICE CARE 1
135 HYPERSENSITIVITY 1
136 HYPERSOMNIA 1
137 HYPOTONIA 1
138 IMPAIRED QUALITY OF LIFE 1
139 INCORRECT DOSE ADMINISTERED 1
140 INSOMNIA 1
141 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 1
142 LOSS OF CONSCIOUSNESS 1
143 LUNG ADENOCARCINOMA 1
144 MENSTRUATION IRREGULAR 1
145 MOVEMENT DISORDER 1
146 MUSCLE INJURY 1
147 MYALGIA 1
148 NEUROLOGICAL SYMPTOM 1
149 OROPHARYNGEAL DISCOMFORT 1
150 PAIN 1
151 PAIN IN JAW 1
152 PANIC ATTACK 1
153 PARKINSONISM 1
154 PHYSICAL EXAMINATION ABNORMAL 1
155 PNEUMONIA 1
156 POLYDIPSIA 1
157 PROCEDURAL PAIN 1
158 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1
159 PRODUCT COLOUR ISSUE 1
160 PRODUCT DISPENSING ISSUE 1
161 PRODUCT DOSE OMISSION 1
162 PRODUCT LEAKAGE 1
163 PRODUCT RESIDUE PRESENT 1
164 PRODUCT SIZE ISSUE 1
165 PULSELESS ELECTRICAL ACTIVITY 1
166 PURULENT DISCHARGE 1
167 PYREXIA 1
168 REBOUND EFFECT 1
169 RESPIRATORY ARREST 1
170 RESTLESSNESS 1
171 RETCHING 1
172 SECRETION DISCHARGE 1
173 SEDATION 1
174 SENSATION OF FOREIGN BODY 1
175 SENSORY PROCESSING SENSITIVITY 1
176 SITTING DISABILITY 1
177 SKIN WEEPING 1
178 SLEEP TALKING 1
179 SOLILOQUY 1
180 SPEECH DISORDER 1
181 SYSTEMIC TOXICITY 1
182 TARDIVE DYSKINESIA 1
183 THERAPEUTIC PRODUCT EFFECT DECREASED 1
184 THINKING ABNORMAL 1
185 THROMBOCYTOPENIA 1
186 TOOTHACHE 1
187 TRANSIENT GLOBAL AMNESIA 1
188 URINARY RETENTION 1
189 URTICARIA 1
190 VOMITING PROJECTILE 1
191 WRONG PRODUCT ADMINISTERED 1
192 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1